Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-494 is a small, non-coding RNA encoded by the MIR494 gene in humans. As a microRNA, miR-494 regulates gene expression post-transcriptionally, primarily inhibiting translation or inducing degradation of specific mRNAs. It plays diverse roles in cellular functions, impacting cell proliferation, apoptosis, and senescence, and is subject to context- and tissue-specific regulation. In cancer biology, miR-494 can function both as an oncogene and tumor suppressor by targeting signaling pathways such as PTEN/PI3K, TGF-β, WNT, and JAK-STAT, as well as by epigenetically silencing other invasion-suppressor miRNAs through DNA methylation. This dual behavior leads to its use as a prognostic or diagnostic biomarker in several malignancies, though it presents challenges for therapeutic targeting due to its pleiotropic and highly context-dependent actions.
MicroRNA-494 inhibits target mRNA translation and/or degradation via the RNA-induced silencing complex (RISC). It also regulates the DNA methylation status of tumor suppressor miRNAs by inhibiting TET methylcytosine dioxygenase, and suppresses key signaling proteins via sequence-specific targeting (e.g., PTEN, IGF2BP1).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-494 (miR-494).